| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| CPC538A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
50 µg |
Please Inquire |
 |
BUY
|
| CPC538B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC524A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S1 Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC524B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S1 Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC530B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbF712, mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC530A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbF712, mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC531B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbH722, mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC531A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S2, Clone AbH722, mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC537A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC537B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC517B |
Human Anti-SARS-CoV-2 Nucleocapsid (AbD207) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC517A |
Human Anti-SARS-CoV-2 Nucleocapsid (AbD207) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC518B |
Human Anti-SARS-CoV-2 Nucleocapsid (AbG733) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC518A |
Human Anti-SARS-CoV-2 Nucleocapsid (AbG733) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC523B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC522B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC523A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC522A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC521A |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC521B |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC520A |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC520B |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC542C |
Human Anti-SARS-CoV-2 Spike-RBD (002-S21F2) Broad-Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC526A |
Human Anti-SARS-CoV-2 Spike-RBD (Clone AbG123) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC526B |
Human Anti-SARS-CoV-2 Spike-RBD (Clone AbG123) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC510A |
Human Anti-SARS-CoV-2 Spike-RBD (Clone VHH-72-Fc) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC510B |
Human Anti-SARS-CoV-2 Spike-RBD (Clone VHH-72-Fc) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC513A |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC513B |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC525A |
Human Anti-SARS-CoV-2 Spike-RBD (S309) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC525B |
Human Anti-SARS-CoV-2 Spike-RBD (S309) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC539C |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC539A |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC539B |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC511B |
Human Anti-SARS-CoV-2 Spike-RBD Casirivimab(REGN10933) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC511A |
Human Anti-SARS-CoV-2 Spike-RBD Casirivimab(REGN10933) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC516A |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC516B |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC512B |
Human Anti-SARS-CoV-2 Spike-RBD Imdevimab (REGN10987) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541C |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC541A |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC541B |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC519A |
Mouse Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC519B |
Mouse Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| DVV00315B |
Research Grade Adintrevimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00315A |
Research Grade Adintrevimab |
100 ug |
$420.00
|
|
BUY
|
| DVV00311A |
Research Grade Amubarvimab |
100 ug |
$420.00
|
|
BUY
|
| DVV00311B |
Research Grade Amubarvimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00321A |
Research Grade Anti-SARS-CoV-2 RBD (S2K146) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00321B |
Research Grade Anti-SARS-CoV-2 RBD (S2K146) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00323A |
Research Grade Anti-SARS-CoV-2 RBD (S2N28) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00323B |
Research Grade Anti-SARS-CoV-2 RBD (S2N28) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00324B |
Research Grade Anti-SARS-CoV-2 RBD (S2X259) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00324A |
Research Grade Anti-SARS-CoV-2 RBD (S2X259) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00322A |
Research Grade Anti-SARS-CoV-2 RBD (S2X324) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00322B |
Research Grade Anti-SARS-CoV-2 RBD (S2X324) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00336B |
Research Grade Anti-SARS-CoV-2 S2 subunit FP Neutralizing (COV44-79) mAb |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00336A |
Research Grade Anti-SARS-CoV-2 S2 subunit FP Neutralizing (COV44-79) mAb |
100 µg |
$475.00
|
|
BUY
|
| DVV00503A |
Research Grade Anti-SARS-CoV-2 S2 subunit SH Neutralizing (WS6) mAb |
100 µg |
$405.00
|
|
BUY
|
| DVV00503B |
Research Grade Anti-SARS-CoV-2 S2 subunit SH Neutralizing (WS6) mAb |
1.0 mg |
$1,485.00
|
|
BUY
|
| DVV00332A |
Research Grade Anti-SARS-CoV-2 Spike Protein/RBD Broad-Neutralizing Antibody (002-S21F2) |
100 µg |
$475.00
|
|
BUY
|
| DVV00332B |
Research Grade Anti-SARS-CoV-2 Spike Protein/RBD Broad-Neutralizing Antibody (002-S21F2) |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00318A |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2E12) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00318B |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2E12) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00317A |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
100 µg |
$420.00
|
|
BUY
|
| DVV00317B |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00317B-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
1.0 mg |
$2,310.00
|
|
BUY
|
| DVV00317X-BT |
Research Grade Anti-SARS-CoV-2 Spike-RBD (S2H97) mAb, Biotin labeled |
0.5 mg |
$1,485.00
|
|
BUY
|
| DVV00303B |
Research Grade Bamlanivimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00303A |
Research Grade Bamlanivimab |
100 ug |
$420.00
|
|
BUY
|
| DVV00319B |
Research Grade Bebtelovimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00319A |
Research Grade Bebtelovimab |
100 µg |
$420.00
|
|
BUY
|
| DVV00309B |
Research Grade Beludavimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00309A |
Research Grade Beludavimab |
100 ug |
$420.00
|
|
BUY
|
| DVV00304B |
Research Grade Casirivimab |
1.0 ug |
$1,520.00
|
|
BUY
|
| DVV00304A |
Research Grade Casirivimab |
100 ug |
$420.00
|
|
BUY
|
| DVV00302A |
Research Grade Cilgavimab |
100 ug |
$420.00
|
|
BUY
|
| DVV00302B |
Research Grade Cilgavimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00326A |
Research Grade Crexavibart |
100 µg |
$420.00
|
|
BUY
|
| DVV00326B |
Research Grade Crexavibart |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00320B |
Research Grade DXP-604 |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00320A |
Research Grade DXP-604 |
100 µg |
$420.00
|
|
BUY
|
| DVV00314B |
Research Grade Enuzovimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00314A |
Research Grade Enuzovimab |
100 ug |
$420.00
|
|
BUY
|
| DVV00306A |
Research Grade Etesevimab |
100 ug |
$475.00
|
|
BUY
|
| DVV00306B |
Research Grade Etesevimab |
1.0 mg |
$1,715.00
|
|
BUY
|
| DVV00305A |
Research Grade Imdevimab |
100 ug |
$420.00
|
|
BUY
|
| DVV00305B |
Research Grade Imdevimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00325B |
Research Grade JMB2002/Ab2001.08 |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00325A |
Research Grade JMB2002/Ab2001.08 |
100 µg |
$420.00
|
|
BUY
|
| DVV00313B |
Research Grade Lomtegovimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00313A |
Research Grade Lomtegovimab |
100 ug |
$420.00
|
|
BUY
|
| DVV00327A |
Research Grade Masavibart |
100 µg |
$420.00
|
|
BUY
|
| DVV00327B |
Research Grade Masavibart |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00328A |
Research Grade Nepuvibart |
100 µg |
$420.00
|
|
BUY
|
| DVV00328B |
Research Grade Nepuvibart |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00329B |
Research Grade Ogalvibart |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00329A |
Research Grade Ogalvibart |
100 µg |
$420.00
|
|
BUY
|
| DVV00330B |
Research Grade Plutavimab |
1.0 mg |
$1,520.00
|
|
BUY
|
| DVV00330A |
Research Grade Plutavimab |
100 µg |
$420.00
|
|
BUY
|
